Derek Thompson on 2025
I think this was a really bad year for American politics, a mediocre year for the American economy, and an exceptional year for America. In 12 months, you’ve got – the largest decline in murder rate ever recorded – huge declines in traffic fatalities, drug overdoses, and suicide – first ever personalized gene editing treatment […]
What to know as first FDA-approved GLP-1 pill for weight loss heads for pharmacies
The FDA has approved the first GLP-1 pill for weight loss and it’s expected in pharmacies in the coming weeks. Dr. Holly Lofton, director of the Medical Weight Management Program at NYU Langone, joins CBS News to discuss. CBS News 24/7 is the premier anchored streaming news service from CBS News and Stations that is […]
Heartbreakingly Shortsighted
Trump and his throwback henchmen have set scientific research back for decades. This piece from the Atlantic (gift link) spells it out and it’s just so depressing: Some of those losses are straightforward: Since the beginning of 2025, “all, or nearly all, federal agencies that supported research in some way have decreased the size of […]
Oprah Breaks Silence on Her One Unexpected Side-Effect of Popular Weight Loss Drug
Talk show queen Oprah Winfrey, who will be turning 72 in January and will be releasing a new book she co-wrote with obesity expert Dr. Ania M. Jastreboff, “Enough: Your Health, Your Weight and What It’s Like to Be Free,” is also celebrating the weight she has lost over the course of the last two and a […]
Oprah’s Wild Booze Confession: Talk Show Legend, 71, Admits to Downing ’17 Shots in One Night’ Before Weight Loss Drugs Made Her Quit Drinking Alcohol
Oprah Winfrey revealed she used to be able to ‘drink everyone under the table’ before GLP-1’s took away her desire for alcohol.
Medifast New Product Line Planned: Can Innovation Reignite Demand?
Medifast, Inc. MED is strategically transitioning beyond its traditional identity as a weight-loss company toward becoming a broader leader in metabolic health. As part of this evolution, the company plans to introduce a new product line next year, reflecting its long-term focus on advancing science-driven health solutions. This upcoming launch is centered on the science […]
HIMS Scales AI-Enabled Care as Platform Depth and Engagement Expand
The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, has consistently positioned technology and clinical infrastructure at the core of its operating model. The platform integrates digital intake, electronic medical records (EMR), prescription workflows and fulfillment into a single end-to-end system, allowing licensed providers to deliver personalized care at scale. This infrastructure […]
6 new care and payment models CMS introduced in 2025
CMS introduced several new care and payment models in 2025, many focused on drug pricing, chronic disease management and prevention: 1. CMS published plans Dec. 23 for its voluntary “Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth” — or BALANCE — model. Under the model, CMS will negotiate reduced prices with GLP-1 manufacturers for […]
Can Amgen’s MariTide Take on Leaders in the Obesity Space?
Amgen AMGN is one of the few companies with a late-stage obesity candidate in its pipeline. The company is developing MariTide, an investigational GLP-1/GIP receptor agonist, as part of its comprehensive MARITIME phase III program in obesity. With this drug, Amgen intends to take on Eli Lilly LLY and Novo Nordisk NVO, which currently dominate […]
Obesity efforts dominate dealmaking in 2025
When glucagon-like peptide-1 (GLP-1) receptor agonists entered the market for obesity and overweight indications in recent years, the uptake and enthusiasm drove investor excitement for companies advancing any of the new mechanisms in the space.